Article Information
History
- July 14, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Ammal Abbasi1,2,3,4,5,
- Christopher D. Steele1,2,3,
- Erik N. Bergstrom1,2,3,
- Azhar Khandekar1,2,3,4,
- Akanksha Farswan6,7,
- Rana R. Mckay3,
- Nischalan Pillay6,7 and
- Ludmil B. Alexandrov1,2,3,4,5,*
- 1Department of Cellular and Molecular Medicine, UC San Diego, La Jolla, CA, 92093, USA
- 2Department of Bioengineering, UC San Diego, La Jolla, CA, 92093, USA
- 3Moores Cancer Center, UC San Diego, La Jolla, CA, 92037, USA
- 4Bioinformatics and Systems Biology Graduate Program, UC San Diego, La Jolla, CA, 92093, USA
- 5Sanford Stem Cell Institute, University of California San Diego, La Jolla, CA 92037
- 6Research Department of Pathology, Cancer Institute, University College London, London, WC1E 6BT, UK
- 7Department of Cellular and Molecular Pathology, Royal National Orthopaedic Hospital NHS Trust, Stanmore, HA7 4LP, UK
- ↵*Correspondence should be addressed to L2alexandrov{at}health.ucsd.edu.
Posted July 14, 2024.
Detecting HRD in whole-genome and whole-exome sequenced breast and ovarian cancers
